Riverain Technologies has developed ClearRead Xray, a suite of five applications that have received FDA clearance, aimed at improving the speed and precision of interpreting chest X-rays within healthcare settings, all without the need for extra equipment, procedures, or exposure to radiation. This innovative platform utilizes specialized suppression technology to create a clear view of the chest, which significantly aids in the swift and precise identification of cardiothoracic conditions. Among its standout features are the generation of bone-suppressed images that enhance visualization, the ability to spot potential lung cancer nodules, a decrease in the time required to read portable X-rays, automatic comparisons with previous examinations to emphasize changes, and compatibility across various imaging devices and protocols throughout the enterprise. Additionally, the ClearRead Xray Bone Suppress feature notably enhances soft tissue visibility by minimizing the presence of bone structures in digital images, thereby assisting radiologists in uncovering nodules that may have previously gone unnoticed. This comprehensive approach not only boosts diagnostic capabilities but also streamlines workflow in busy medical environments.